Search
Saul Ewing LLP, a full-service national law firm, is proud to announce that Trusts & Estates Practice Co-Chair Jeffrey Glaser was included in The Daily Record’s 2024 Estate and Trust Law Power List. This group is composed of the most influential and respected practitioners in the estate & trust law...
January 26, 2024 - With AI poised to reshape the practice of law and businesses in every industry, Saul Ewing is pleased to partner with the ABA’s Intellectual Property Litigation Committee in forming the AI Subcommittee. The AI Subcommittee will monitor legal and technological developments in this...
(Baltimore, MD, January 5, 2024) - Saul Ewing LLP today announced that Jeffrey S. Glaser, Partner and Chair of the Firm’s Trusts & Estates Practice Group, has authored the 19th Supplement to the Maryland Estate Planning, Wills and Trusts Library: Forms and Practice Manual . The 19th Supplement was...
Saul Ewing LLP, a full-service national law firm, today announced that the firm was recognized as Band 1 for Private Wealth Law in Maryland in Chambers High Net Worth 2023 . Additionally, Jeff Glaser, chair of the firm's Personal Wealth, Estates & Trusts Practice, was ranked as a Band 1 attorney...
Francelina Perdomo Klukosky brings extensive experience as an intellectual property attorney to her new role as counsel in the firm. Ms. Perdomo Klukosky focuses on both litigation and transactions for clients in the sports and entertainment industries. She is resident in the New York office. Ms...
Saul Ewing LLP, a full-service law firm with attorneys in 16 offices, today announced that 59 attorneys from the Firm received the distinguished honor of being recognized for legal excellence and client service by Chambers USA 2022. Several of the Firm’s practice areas also earned high rankings...
Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...